|
1
|
Pisani P, Parkin DM, Bray F and Ferlay J:
Estimates of the worldwide mortality from 25 cancers in 1990. Int J
Cancer. 83:18–29. 1999. View Article : Google Scholar
|
|
2
|
Cook MB: Non-acid reflux: the missing link
between gastric atrophy and esophageal squamous cell carcinoma? Am
J Gastroenterol. 106:1930–1932. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Higuchi K, Koizumi W, Tanabe S, et al:
Current management of esophageal squamous-cell carcinoma in Japan
and other countries. Gastrointest Cancer Res. 3:153–161.
2009.PubMed/NCBI
|
|
4
|
Chang CY, Cook MB, Lee YC, et al: Current
status of Barrett’s esophagus research in Asia. J Gastroenterol
Hepatol. 26:240–246. 2011.
|
|
5
|
Hongo M, Nagasaki Y and Shoji T:
Epidemiology of esophageal cancer: Orient to Occident. Effects of
chronology, geography and ethnicity. J Gastroenterol Hepatol.
24:729–735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mueller MM and Fusenig NE: Friends or foes
- bipolar effects of the tumour stroma in cancer. Nat Rev Cancer.
4:839–849. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Radisky DC, Kenny PA and Bissell MJ:
Fibrosis and cancer: do myofibroblasts come also from epithelial
cells via EMT? J Cell Biochem. 101:830–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marsh D, Suchak K, Moutasim KA, et al:
Stromal features are predictive of disease mortality in oral cancer
patients. J Pathol. 223:470–481. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447.
2003.PubMed/NCBI
|
|
11
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Surowiak P, Murawa D, Materna V, et al:
Occurence of stromal myofibroblasts in the invasive ductal breast
cancer tissue is an unfavourable prognostic factor. Anticancer Res.
27:2917–2924. 2007.PubMed/NCBI
|
|
13
|
Kellermann MG, Sobral LM, da Silva SD, et
al: Myofibroblasts in the stroma of oral squamous cell carcinoma
are associated with poor prognosis. Histopathology. 51:849–853.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsujino T, Seshimo I, Yamamoto H, et al:
Stromal myofibroblasts predict disease recurrence for colorectal
cancer. Clin Cancer Res. 13:2082–2090. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar
|
|
16
|
Japanese Esophageal Society. Japanese
Classification of Esophageal Cancer, tenth edition: part I.
Esophagus. 6:1–25. 2009. View Article : Google Scholar
|
|
17
|
Sobin LH GM, Gospodarowicz MK and
Wittekind CH: International Union Against Cancer (UICC) TNM
Classification of Malignant Tumors. 7th edition. Wiley-Blackwell;
2009
|
|
18
|
Andl CD, Mizushima T, Nakagawa H, et al:
Epidermal growth factor receptor mediates increased cell
proliferation, migration, and aggregation in esophageal
keratinocytes in vitro and in vivo. J Biol Chem. 278:1824–1830.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Underwood TJ, Derouet MF, White MJ, et al:
A comparison of primary oesophageal squamous epithelial cells with
HET-1A in organotypic culture. Biol Cell. 102:635–644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aoki S, Takezawa T, Uchihashi K, Sugihara
H and Toda S: Non-skin mesenchymal cell types support epidermal
regeneration in a mesenchymal stem cell or myofibroblast
phenotype-independent manner. Pathol Int. 59:368–375. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okawa T, Michaylira CZ, Kalabis J, et al:
The functional interplay between EGFR overexpression, hTERT
activation, and p53 mutation in esophageal epithelial cells with
activation of stromal fibroblasts induces tumor development,
invasion, and differentiation. Genes Dev. 21:2788–2803. 2007.
View Article : Google Scholar
|
|
22
|
Erez N, Truitt M, Olson P, Arron ST and
Hanahan D: Cancer-associated fibroblasts are activated in incipient
neoplasia to orchestrate tumor-promoting inflammation in an
NF-κB-dependent manner. Cancer Cell. 17:135–147. 2010.PubMed/NCBI
|
|
23
|
Sugimoto H, Mundel TM, Kieran MW and
Kalluri R: Identification of fibroblast heterogeneity in the tumor
microenvironment. Cancer Biol Ther. 5:1640–1646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noma K, Smalley KS, Lioni M, et al: The
essential role of fibroblasts in esophageal squamous cell
carcinoma-induced angiogenesis. Gastroenterology. 134:1981–1993.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoshino M, Ishiwata T, Watanabe M, et al:
Expression and roles of keratinocyte growth factor and its receptor
in esophageal cancer cells. Int J Oncol. 31:721–728.
2007.PubMed/NCBI
|
|
26
|
Ren Y, Cao B, Law S, et al: Hepatocyte
growth factor promotes cancer cell migration and angiogenic factors
expression: a prognostic marker of human esophageal squamous cell
carcinomas. Clin Cancer Res. 11:6190–6197. 2005. View Article : Google Scholar
|
|
27
|
Grugan KD, Miller CG, Yao Y, et al:
Fibroblast-secreted hepatocyte growth factor plays a functional
role in esophageal squamous cell carcinoma invasion. Proc Natl Acad
Sci USA. 107:11026–11031. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang C, Fu L, Fu J, et al: Fibroblast
growth factor receptor 2-positive fibroblasts provide a suitable
microenvironment for tumor development and progression in
esophageal carcinoma. Clin Cancer Res. 15:4017–4027. 2009.
View Article : Google Scholar
|
|
29
|
Lederle W, Depner S, Schnur S, et al: IL-6
promotes malignant growth of skin SCCs by regulating a network of
autocrine and paracrine cytokines. Int J Cancer. 128:2803–2814.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gaggioli C, Hooper S, Hidalgo-Carcedo C,
et al: Fibroblast-led collective invasion of carcinoma cells with
differing roles for RhoGTPases in leading and following cells. Nat
Cell Biol. 9:1392–1400. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bohn W, Wiegers W, Beuttenmüller M and
Traub P: Species-specific recognition patterns of monoclonal
antibodies directed against vimentin. Exp Cell Res. 201:1–7. 1992.
View Article : Google Scholar : PubMed/NCBI
|
